跳至主要内容
临床试验/JPRN-UMIN000026897
JPRN-UMIN000026897已完成2 期

A prospective randomized controlled trial of selective conventional TACE vs. balloon occluded TACE with epirubicin for hepatocellular carcinoma - A randomized controlled trial of selective conventional TACE vs. balloon occluded TACE for hepatocellular carcinoma

agoya University Hospital Department of Gastroenterology and Hepatology0 个研究点目标入组 164 人开始时间: 2017年4月10日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
164

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Extrahepatic metastasis. 2. Ruptured HCC nodules in which TACE is planned. 3. Prior surgical reconstruction or endoscopic treatment of the biliary tract. 4. Severe arterio portal or arterio venous shunts in the liver. 5. Refractory ascites or pleural effusion. 6. Allergy to contrast medium that precludes angiography. 7. Previously registered patients in this study. 8. Pregnancy, nursing women, or women of childbearing potential, and men who are sexually active and not willing or able to use medically acceptable forms of contraception. 9. Comorbid diseases as cardiac failure, recent myoinfarction, renal failure, active infection, active gastrointestinal bleeding, active associated cancers, hepatic encephalopathy or uncontrolled psychologic disorders, and serious allergy to medicine. 10. Not eligible because of safety issues judged by investigators.

研究者

发起方
agoya University Hospital Department of Gastroenterology and Hepatology

相似试验